A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Approximately 450 patients will be randomized to receive mifepristone or placebo for 7 days
followed by antidepressant. The purpose is to compare the efficacy of mifepristone followed
by antidepressant versus placebo followed by antidepressant in reducing psychotic symptoms in
patients with a diagnosis of psychotic depression.